Search results for " Skin"

showing 10 items of 1220 documents

Occurrence and legislation of mycotoxins in food and feed from Morocco

2009

Mycotoxins are natural food and feed contaminants, mainly produced by moulds of genera Aspergillus, Penicillium and Fusarium. The number of mycotoxins known to exert toxic effect on human and animal health is constantly increasing as well as the legislative provisions taken to control their presence in food and feed. Morocco, a North African country, surrounded by the Mediterranean Sea and Atlantic Ocean, has a climate characterized by high humidity and high temperature which favor growth of moulds. This paper gives an overview about the contamination levels and the occurrence of some mycotoxins (e.g. aflatoxins, ochratoxin A, and Fusarium toxins) in cereals, bread, milk, spices, wine, oliv…

Ochratoxin AFusariumAflatoxinDried fruitbiologybusiness.industrydigestive oral and skin physiologyfood and beveragesFood safetybiology.organism_classificationToxicologychemistry.chemical_compoundGeographychemistryFood sciencebusinessMycotoxinZearalenoneFood ScienceBiotechnologyFood contaminantFood Control
researchProduct

Gaining deeper insight into aroma perception: An integrative study of the oral processing of breads with different structures

2017

WOS:000394071900015; International audience; The objective of this study was to investigate for the first time the influence of bread structure, volatile compounds, and oral processing on aroma perception. 3 types of French baguette were created using the same raw ingredients but different bread-making processes; they consequently varied in their crumb and crust structures. We characterized the initial volatile profiles of two bread structural subtypes-namely bread crumb and bread crumb with crust-using proton transfer reaction-mass spectrometry (PTR-MS) headspace analysis. Three types of bread were characterized by thirty-nine ion fragments from m/z 45 to 139. We then conducted a study in …

Olfactory perceptionAdultMalecrumb[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SDV]Life Sciences [q-bio]FlourcrustreleaseGas Chromatography-Mass SpectrometryBolusYoung Adult0404 agricultural biotechnologyHumansFood scienceProgressive profilingAromaFlavorTriticum2. Zero hungerprofileVolatile Organic CompoundssalivaChromatographybreakdownbiologyChemistrydigestive oral and skin physiologySensory analysesfood and beverages04 agricultural and veterinary sciencesBreadreaction-mass-spectrometrybiology.organism_classificationOlfactory Perception040401 food scienceFlavorTasteOdorantsimpactFemaleGas chromatography–mass spectrometryflavor compoundstexture[SDV.AEN]Life Sciences [q-bio]/Food and NutritionProton transfer reaction-mass spectrometry (PTR-MS)Food Science
researchProduct

Hypothalamus-olfactory system crosstalk: orexin a immunostaining in mice

2012

It is well known that olfaction influences food intake, and conversely, that an individual’s nutritional status modulates olfactory sensitivity. However, what is still poorly understood is the neuronal correlate of this relationship, as well as the connections between the olfactory bulb and the hypothalamus. The goal of this report is to analyze the relationship between the olfactory bulb and hypothalamus, focusing on orexin A immunostaining, a hypothalamic neuropeptide that is thought to play a role in states of sleep/wakefulness. Interestingly, orexin A has also been described as a food intake stimulator. Such an effect may be due in part to the stimulation of the olfactory bulbar pathway…

Olfactory systemmedicine.medical_specialtyLateral hypothalamus[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionNeuroscience (miscellaneous)Olfactionolfactory systemBiology03 medical and health sciencesCellular and Molecular NeuroscienceOrexin-A0302 clinical medicineInternal medicinemental disordersmedicineFood and Nutritionhypothalamus030304 developmental biologyOriginal Research0303 health sciencesimmunocytologyOlfactory tubercledigestive oral and skin physiologyimmunohistologyaobfood intake behaviourOrexinOlfactory bulbaob;food intake behaviour;hypothalamus;immunohistology;mob;olfactory system;orexin aEndocrinologymobnervous systemAlimentation et NutritionWakefulnessorexin aAnatomyfood intake behaviorNeuroscience[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgerypsychological phenomena and processeshormones hormone substitutes and hormone antagonistsNeuroscience
researchProduct

Exploratory outcome analyses according to stage and residual disease in the ICON7 trial of front-line carboplatin/paclitaxel (CP) ± bevacizumab (BEV)…

2015

5548 Background: In ICON7, progression-free survival (PFS) was significantly improved in patients (pts) receiving BEV with front-line CP and continued as a single agent [Perren 2011] but no overall...

OncologyCancer Researchmedicine.medical_specialtyBevacizumabbusiness.industrydigestive oral and skin physiologyFront lineDiseasemedicine.diseaseCarboplatin/paclitaxelSurgeryOncologyInternal medicineMedicineSingle agentIn patientStage (cooking)businessOvarian cancermedicine.drugJournal of Clinical Oncology
researchProduct

Management of Toxicity Induced by Anti-EGFR Therapy in Metastatic Colorectal Cancer

2013

Use of anti-epidermal growth factor receptor (anti-EGFR) agents has yielded significant advances in the treatment of patients with metastatic colorectal cancer. In fact these drugs, which include the monoclonal antibodies cetuximab and panitumumab, can be delivered both as a single agent and in combination with chemotherapy, achieving better survival and quality of life and in some cases also resectability of metastases. However, these agents can result in the development of toxicities that are usually different from those observed with chemotherapy alone. For the management of these adverse effects, proper knowledge is mandatory. Skin toxicity is the most frequent adverse effect. Other tox…

OncologyColorectal cancerSettore MED/06 - Oncologia Medicamedicine.medical_treatmentPulmonary FibrosisCetuximabPharmacologyPrurituMagnesiumEpidermal growth factor receptorParonychiaCancerSkinbiologyCetuximabPanitumumabGastroenterologyfood and beveragesCutaneouOncologyToxicityMetastaticmedicine.drugDiarrheamedicine.medical_specialtyGastrointestinalAnti-epidermal growth factor receptorColonReactionInternal medicineRashmedicinePanitumumabToxicity; Epidermal growth factor receptor; Anti-epidermal growth factor receptor; Cetuximab; Panitumumab; Antibody; Metastatic; Colon; Rectum; Cancer; Treatment; Skin; Rash; Cutaneous; Pruritus; Xerosis; Paronychia; Hypomagnesemia; Magnesium; Gastrointestinal; Diarrhea; Infusion; Reaction; Pulmonary FibrosisInfusionAdverse effectAntibodyXerosisChemotherapyHepatologyToxicitybusiness.industryEpidermal growth factor receptorPruritusRectumCancermedicine.diseaseXerosiTreatmentCutaneousbiology.proteinHypomagnesemiabusiness
researchProduct

The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergr…

2022

Abstract Background: The management of melanoma patients with metastatic sentinel nodes (SN) is evolving based on the results of trials questioning the impact of completion lymph node dissection (CLND) and demonstrating the efficacy of new adjuvant treatments. In this landscape, new prognostic tools for fine risk stratification are eagerly sought to optimize the therapeutic path of these patients. Methods: A retrospective cohort of 2,086 patients treated with CLND after a positive SN biopsy in thirteen Italian Melanoma Centers was reviewed. Overall survival (OS) was the outcome of interest; included independent variables were the following: age, gender, primary melanoma site, Breslow thickn…

OncologyMaleTreatment of cutaneous melanomamedicine.medical_specialtyCompletion lymph node dissectionSkin NeoplasmsCLND; Completion lymph node dissection; Melanoma; Metastatic melanoma in the sentinel nodes; Nomogram; Overall survival; Prognostic factors; Risk stratification; Treatment of cutaneous melanoma; Tumor burden; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Prognosis; Retrospective Studies; Sentinel Lymph Node Biopsy; Tumor Burden; Lymphadenopathy; Melanoma; Sentinel Lymph Node; Skin NeoplasmsTumor burdenSettore MED/19 - Chirurgia PlasticaLymphadenopathyPrognostic factorsNomogramInternal medicineBiopsymedicineMetastatic melanoma in the sentinel nodesHumansCLNDOverall survivalMelanomaCLND; Completion lymph node dissection; Melanoma; Metastatic melanoma in the sentinel nodes; Nomogram; Overall survival; Prognostic factors; Risk stratification; Treatment of cutaneous melanoma; Tumor burdenRisk stratificationRetrospective Studiesmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaTumor burdenSentinel nodemedicine.diseasePrognosisLymphatic MetastasisLymph Node ExcisionSentinel Lymph Nodebusiness
researchProduct

Vulvar cancer: a review for dermatologists.

2015

Vulvar malignancies are important tumors of the female reproductive system. They represent a serious health issue with an incidence between 2 and 7 per 100,000 and year. We provide a review about most important cancer entities, i.e., melanoma, squamous cell carcinoma, basal cell carcinoma, neuroendocrine cancer, and skin adnexal malignancies. Squamous cell carcinoma is the most common vulvar malignancy that can develop from vulvar intraepithelial neoplasia or de novo. Basal cell carcinoma represents only 2 % of all vulvar cancers. Melanoma of the vulva exists in two major types—superficial spreading and acral lentiginous. A special feature is the occurrence of multiple vulvar melanomas. Of …

Oncologymedicine.medical_specialtySkin NeoplasmsMalignancyVulvaVulvaDiagnosis DifferentialVulva · Squamous cell carcinoma · Basal cell carcinoma · Melanoma · Paget’s disease · Adnexal carcinomasInternal medicineCarcinomamedicineSettore MED/35 - Malattie Cutanee E VenereeHumansBasal cell carcinomaMelanomaNeoplasm StagingSkinintegumentary systemVulvar Neoplasmsurogenital systembusiness.industryMelanomaCancerGeneral MedicineVulvar cancermedicine.diseaseVulvar intraepithelial neoplasiaPrognosisDermatologyfemale genital diseases and pregnancy complicationsNeuroendocrine Tumorsmedicine.anatomical_structurePaget Disease ExtramammaryCarcinoma Basal CellCarcinoma Squamous CellFemaleNeoplasms Adnexal and Skin AppendagebusinessCarcinoma in SituWiener medizinische Wochenschrift (1946)
researchProduct

Central Nervous System Malignancies

2021

The primitive neoplasms of the central nervous system (CNS) are a rare and heterogeneous group of malignancies. Brain metastases (BMs) are the most frequent intracranial tumor, and their incidence is rising in the last few decades. Primary tumors more often complicated by BMs are lung cancer, breast cancer, and melanoma. Neuroimaging techniques, mainly magnetic resonance imaging (MRI), play a key role for the diagnosis of BMs. The management of BMs is based on a multimodal approach, including symptomatic treatment, local treatment, such as surgery, stereotactic radiosurgery (SRS), and whole brain radiotherapy (WBRT), and systemic therapy, such as chemotherapy, target therapy, or immunothera…

Oncologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentMelanomaeducationdigestive oral and skin physiologyMultimodal therapyMagnetic resonance imagingmedicine.diseaseRadiosurgeryRadiation therapystomatognathic diseasesBreast cancerInternal medicinemedicineNeurosurgeryLung cancerbusiness
researchProduct

Gains and losses related to career transitions within organisations

2014

Abstract With this study we aim to look at potential gains and losses in terms of higher career satisfaction and increased strain levels as a consequence of intraorganisational upward career transitions. Following the idea of a matching principle, we further expected stressors to mediate the relationship between transitions and strain, and resources to mediate the relationship between transitions and career satisfaction. Altogether, N = 581 employees from 11 German organisations filled in an online questionnaire twice, with a time lag of one year. About 20% of the respondents stated having experienced upward transitions. SEM analyses using latent difference scores for the mediators and depe…

Organizational Behavior and Human Resource ManagementVariablesmedia_common.quotation_subjectdigestive oral and skin physiologyeducationStressorTime lagComputer-assisted web interviewingTime pressureCareer satisfactionhumanitiesEducationLife-span and Life-course StudiesPsychologySocial psychologyApplied PsychologyAutonomymedia_commonJournal of Vocational Behavior
researchProduct

Dosimetric characteristics of a new unit for electronic skin brachytherapy

2013

PURPOSE: Brachytherapy with radioactive high dose rate (HDR) (192)Ir source is applied to small skin cancer lesions, using surface applicators, i.e. Leipzig or Valencia type. New developments in the field of radiotherapy for skin cancer include electronic brachytherapy. This technique involves the placement of an HDR X-ray source close to the skin, therefore combining the benefits of brachytherapy with the reduced shielding requirements and targeted energy of low energy X-rays. Recently, the Esteya(®) Electronic Brachytherapy System (Esteya EBS, Elekta AB-Nucletron, Stockholm, Sweden) has been developed specifically for HDR brachytherapy treatment of surface lesions. The system provides rad…

Original Paperelectronic brachytherapybusiness.industrymedicine.medical_treatmentTreatment durationSuperficial radiotherapyBrachytherapyElectronic skinsuperficial radiotherapyRadiation therapyLow energyOncologynonmelanoma skin-cancermedicineskin brachytherapyRadiology Nuclear Medicine and imagingNuclear medicinebusinessDose rateDepth doseJournal of Contemporary Brachytherapy
researchProduct